Beactica will become known for creating breakthrough therapeutics that transform the prospects for patients suffering from life-threatening cancers
We create novel therapeutics that will benefit cancer patients across the world. We will bring hope to those patients and their families. We will impress the giants of the pharmaceutical industry with our scientific breakthroughs. We will succeed in selecting and targeting key disease proteins of vital importance for cancer. The name Beactica will be recognised to represent outstanding innovation and scientific excellence. We will be proud of how our hard work enabled Beactica to transition into a clinical-stage company. We will feel a tremendous satisfaction over the long-lasting impact that we have created, and the lives that we thereby touched.
To address genetically defined cancers with high unmet medical need by targeting synthetically lethal disease proteins with allosteric modulators and targeted protein degraders (PROTACs)
Integrity, Excellence, Innovation and Diligence are at the core of what we do at Beactica. By combining our creative and curious outlook with our world-class science, we can make a difference where it really matters.
We believe that real progress can only emerge from honesty, respect, openness, trust and by following the science. Therefore accountability, transparency and responsibility are non-negotiables at Beactica.
We are driven to perform cutting-edge, world-class science with the highest degree of knowledge, competence and accuracy – for each other, our investors, our partners and patients.
We foster a fertile environment for innovation through cultivating a culture of continuous learning, curiosity, boldness and collaboration.
True breakthroughs do not come around accidentally. At Beactica, we pride ourselves on our drive, determination and perseverance to discover life-changing therapies.
Underpinning the foundation of our four core values is collaboration, which is present at every level. Our team’s teamwork, commitment and optimism enable us to achieve our goals.
Sign up for the Beactica newsletter to receive our latest news and updates